Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/ITERUM-THERAPEUTICS-PLC-43499891/attualita/Iterum-annuncia-la-somministrazione-del-primo-paziente-in-Reassure-uno-studio-clinico-di-fase-3-sul-42058216/?utm_source=whatsapp&utm_medium=social&utm_campaign=share